# Kewaunee Scientific Corp: overview KEQU · Nasdaq · CIK 55529 · [Technology](/sectors/technology.md) · fiscal year ends Apr 30 Pages: [Overview](/companies/kequ.md) · [Financials](/companies/kequ/financials.md) · [Filings](/companies/kequ/filings.md) · [Insiders](/companies/kequ/insiders.md) Latest reported revenue: [$66.3m](/filings/0000055529-26-000035.md) for Q1 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000055529-26-000035). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [47.8](/filings/0000055529-25-000054.md) | [67.2](/filings/0000055529-26-000009.md) | [77.1 d](/filings/0000055529-26-000020.md) | [71.1](/filings/0000055529-26-000035.md) | [70.1](/filings/0000055529-25-000054.md) | [69.4](/filings/0000055529-26-000009.md) | [71.4 d](/filings/0000055529-26-000020.md) | [66.3](/filings/0000055529-26-000035.md) | | Gross margin | % | [29.2%](/filings/0000055529-25-000054.md) | [27.4%](/filings/0000055529-26-000009.md) | [31.2% d](/filings/0000055529-26-000020.md) | [29.4%](/filings/0000055529-26-000035.md) | [28.1%](/filings/0000055529-25-000054.md) | [26.7%](/filings/0000055529-26-000009.md) | [29.8% d](/filings/0000055529-26-000020.md) | [29.6%](/filings/0000055529-26-000035.md) | | Operating margin | % | [9.3%](/filings/0000055529-25-000054.md) | [3.3%](/filings/0000055529-26-000009.md) | [11.0% d](/filings/0000055529-26-000020.md) | [6.8%](/filings/0000055529-26-000035.md) | [5.9%](/filings/0000055529-25-000054.md) | [3.7%](/filings/0000055529-26-000009.md) | [7.3% d](/filings/0000055529-26-000020.md) | [4.8%](/filings/0000055529-26-000035.md) | | Net margin | % | [6.3%](/filings/0000055529-26-000009.md) | [2.0%](/filings/0000055529-26-000009.md) | [6.3% d](/filings/0000055529-26-000020.md) | [4.3%](/filings/0000055529-26-000035.md) | [3.5%](/filings/0000055529-26-000009.md) | [1.0%](/filings/0000055529-26-000009.md) | [4.7% d](/filings/0000055529-26-000020.md) | [2.6%](/filings/0000055529-26-000035.md) | | Diluted EPS | $ per share | [1.01](/filings/0000055529-25-000054.md) | [0.45](/filings/0000055529-26-000009.md) | not reported | [1.04](/filings/0000055529-26-000035.md) | [0.82](/filings/0000055529-25-000054.md) | [0.23](/filings/0000055529-26-000009.md) | not reported | [0.58](/filings/0000055529-26-000035.md) | | Free cash flow | $m | [7.8 d](/filings/0000055529-25-000054.md) | [(3.0) d](/filings/0000055529-26-000009.md) | [8.9 d](/filings/0000055529-26-000020.md) | [5.0](/filings/0000055529-26-000035.md) | [(5.8) d](/filings/0000055529-25-000054.md) | [11.0 d](/filings/0000055529-26-000009.md) | [4.5 d](/filings/0000055529-26-000020.md) | [1.2](/filings/0000055529-26-000035.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-04-30) | FY2023 (2023-04-30) | FY2024 (2024-04-30) | FY2025 (2025-04-30) | FY2026 (2026-04-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [169](/filings/0000055529-23-000013.md) | [219](/filings/0000055529-24-000021.md) | [204](/filings/0000055529-25-000026.md) | [240](/filings/0000055529-26-000020.md) | [282](/filings/0000055529-26-000020.md) | | Gross margin | % | [14.3%](/filings/0000055529-23-000013.md) | [16.2%](/filings/0000055529-24-000021.md) | [25.5%](/filings/0000055529-25-000026.md) | [28.6%](/filings/0000055529-26-000020.md) | [28.5%](/filings/0000055529-26-000020.md) | | Operating margin | % | [(1.5%)](/filings/0000055529-23-000013.md) | [2.4%](/filings/0000055529-24-000021.md) | [9.0%](/filings/0000055529-25-000026.md) | [7.4%](/filings/0000055529-26-000020.md) | [5.9%](/filings/0000055529-26-000020.md) | | Net margin | % | [(3.6%)](/filings/0000055529-23-000013.md) | [0.3%](/filings/0000055529-24-000021.md) | [9.2%](/filings/0000055529-25-000026.md) | [4.7%](/filings/0000055529-26-000020.md) | [3.4%](/filings/0000055529-26-000020.md) | | Diluted EPS | $ per share | [(2.20)](/filings/0000055529-23-000013.md) | [0.25](/filings/0000055529-24-000021.md) | [6.38](/filings/0000055529-25-000026.md) | [3.83](/filings/0000055529-26-000020.md) | [3.22](/filings/0000055529-26-000020.md) | | Free cash flow | $m | [(9.8)](/filings/0000055529-23-000013.md) | [(7.9)](/filings/0000055529-24-000021.md) | [15.2](/filings/0000055529-25-000026.md) | [12.6](/filings/0000055529-26-000020.md) | [14.7](/filings/0000055529-26-000020.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/kequ/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $8.5m | 238,111 | | Reduced −7,853 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $6.2m | 175,042 | | Reduced −2,297 | | [Minerva Advisors LLC](/funds/1541536.md) | 2026-06-30 | $5.3m | 149,410 | | Added +12,705 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.9m | 110,051 | | Reduced −2,462 | | [PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.](/funds/1238990.md) | 2026-06-30 | $3.7m | 105,545 | | Added +4,843 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $3.4m | 95,311 | | Reduced −3,200 | | [De Lisle Partners LLP](/funds/2011184.md) | 2026-06-30 | $1.9m | 52,626 | | Unchanged | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $1.8m | 49,700 | | Added +1,700 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $1.8m | 49,530 | | Reduced −21 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $885.8k | 24,931 | | Added +452 | ## Recent filings [All 874 filings](/companies/kequ/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-11 | 11:44 ET | [10-Q](/filings/0000055529-26-000035.md) | Quarterly report, period 2026-07-31 | 0000055529-26-000035 | | 2026-09-09 | 16:19 ET | [8-K](/filings/0000055529-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000055529-26-000031 | | 2026-08-27 | 07:58 ET | [8-K](/filings/0000055529-26-000028.md) | 5.07 Shareholder vote results | 0000055529-26-000028 | | 2026-08-26 | 06:10 ET | [8-K](/filings/0000055529-26-000025.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000055529-26-000025 | | 2026-08-25 | 16:20 ET | [8-K](/filings/0000055529-26-000023.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000055529-26-000023 | | 2026-07-07 | 07:53 ET | [DEF 14A](/filings/0001140361-26-027713.md) | Proxy statement, period 2026-08-26 | 0001140361-26-027713 | | 2026-06-26 | 17:09 ET | [10-K](/filings/0000055529-26-000020.md) | Annual report, period 2026-04-30 | 0000055529-26-000020 | | 2026-06-23 | 17:10 ET | [8-K](/filings/0000055529-26-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000055529-26-000017 | | 2026-06-10 | 16:07 ET | [8-K](/filings/0000055529-26-000014.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000055529-26-000014 | | 2026-03-13 | 11:31 ET | [10-Q](/filings/0000055529-26-000009.md) | Quarterly report, period 2026-01-31 | 0000055529-26-000009 | ## Latest annual report [Form 10-K for the fiscal year ended Apr 30, 2026](/filings/0000055529-26-000020.md), filed Jun 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 55529 - Tickers: KEQU - Exchange: Nasdaq - SIC code: 3821 Laboratory Apparatus & Furniture - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.